Development of an Enzyme-Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One-Pot Megamolecule Assembly

Chemistry. 2021 Dec 20;27(71):17843-17848. doi: 10.1002/chem.202103059. Epub 2021 Nov 17.

Abstract

This paper presents an enzyme building block for the assembly of megamolecules. The system is based on the inhibition of the human-derived cellular retinoic acid binding protein II (CRABP2) domain. We synthesized a synthetic retinoid bearing an arylfluorosulfate group, which uses sulfur fluoride exchange click chemistry to covalently inhibit CRABP2. We conjugated both the inhibitor and a fluorescein tag to an oligo(ethylene glycol) backbone and measured a second-order rate constant for the protein inhibition reaction of approximately 3,600 M-1 s-1 . We used this new enzyme-inhibitor pair to assemble multi-protein structures in one-pot reactions using three orthogonal assembly chemistries to demonstrate exact control over the placement of protein domains within a single, homogeneous molecule. This work enables a new dimension of control over specificity, orientation, and stoichiometry of protein domains within atomically precise nanostructures.

Keywords: bioorganic chemistry; enzymes; inhibitors; kinetics; protein structures.

MeSH terms

  • Enzyme Inhibitors*
  • Humans
  • Protein Domains
  • Receptors, Retinoic Acid*

Substances

  • Enzyme Inhibitors
  • Receptors, Retinoic Acid